KD Logo

AKRO Stock Sees Decline of Approximately -0.89% in Last Five Days

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Akero Therapeutics Inc shares valued at $121,913 were sold by Young Jonathan on Apr 01 ’24. At $24.38 per share, Young Jonathan sold 5,000 shares. The insider’s holdings dropped to 263,306 shares worth approximately $5.29 million following the completion of this transaction.

Also, Cheng Andrew sold 1,969 shares, netting a total of over 55,782 in proceeds. Following the sale of shares at $28.33 each, the insider now holds 589,447 shares.

Before that, White William Richard had sold 724 shares from its account. In a trade valued at $20,511, the Chief Financial Officer traded Akero Therapeutics Inc shares for $28.33 each. Upon closing the transaction, the insider’s holdings decreased to 724 shares, worth approximately $1.0 million.

Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid September. As of August 28, 2023, UBS has initiated its “Buy” rating for AKRO. Earlier on January 27, 2023, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for AKRO stock which previously was a “an Equal-weight”.

Analyzing AKRO Stock Performance

During the last five days, there has been a drop of approximately -0.89%. Over the course of the year, Akero Therapeutics Inc shares have dropped approximately -14.00%. Shares of the company reached a 52-week high of $37.00 on 03/04/24 and a 52-week low of $15.32 on 02/06/24. A 50-day SMA is recorded $24.49, while a 200-day SMA reached $28.44. Nevertheless, trading volume fell to 1.05 million shares from 0.75 million shares the previous day.

Support And Resistance Levels for Akero Therapeutics Inc (AKRO)

According to the 24-hour chart, there is a support level at 19.65, which, if violated, would cause prices to drop to 19.23. In the upper region, resistance lies at 20.57. The next price resistance is at 21.07. RSI (Relative Strength Index) is 37.20 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.77, which suggests the price will decrease in the coming days. Percent R is at 55.24%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular

[the_ad id="945"]